MATTHEW STOTTLE: Open Payments
NPI 1871753087 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,268 in 46 payments from 17 companies in 2025. Trend: 2023 $3,430 · 2024 $1,445 · 2025 $2,268
Food & beverage: $1,330Travel & lodging: $938
| Company | Payments | Amount |
|---|---|---|
| Conetic Solutions, Inc. | 1 | $500 |
| Medtronic, Inc. | 4 | $485 |
| Arthrex, Inc. | 3 | $482 |
| ABBVIE INC. | 11 | $206 |
| Abbott Laboratories | 4 | $143 |
| SI-BONE, INC. | 4 | $80 |
| TerSera Therapeutics LLC | 2 | $64 |
| MML US, Inc. | 3 | $46 |
| Forte Bio-Pharma LLC | 3 | $44 |
| PROTEGA PHARMACEUTIALS INC | 2 | $38 |
Products named: INTELLIS ADAPTIVESTIM, INCEPTIV, BOTOX, PROCLAIM, QULIPTA, Prialt, ReActiv8, PROLATE.
Industry payments across NE — which companies pay providers there.
